Singular Genomics Systems... (OMIC)
19.69
-0.11 (-0.56%)
At close: Jan 15, 2025, 1:27 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -94.82M | -90.88M | -98.77M | -27.95M | -12.32M |
| Depreciation & Amortization | 7.22M | 6.03M | 1.13M | 639.00K | 350.00K |
| Stock-Based Compensation | 11.40M | 13.67M | 9.23M | 1.06M | 170.00K |
| Other Working Capital | 677.00K | -1.25M | -4.76M | 1.01M | 171.00K |
| Other Non-Cash Items | 4.79M | 901.00K | 35.48M | 234.00K | -10.00K |
| Deferred Income Tax | n/a | n/a | 4.14M | 281.00K | n/a |
| Change in Working Capital | -2.25M | -16.82M | -2.91M | 858.00K | 415.00K |
| Operating Cash Flow | -73.65M | -87.09M | -51.70M | -24.87M | -11.40M |
| Capital Expenditures | -970.00K | -6.02M | -4.86M | -1.38M | -800.00K |
| Acquisitions | n/a | 33.54M | 126.00M | -25.39M | 30.70M |
| Purchase of Investments | -183.59M | -174.71M | -195.68M | -6.08M | -42.73M |
| Sales Maturities Of Investments | 198.37M | 141.17M | 69.69M | 31.46M | 12.03M |
| Other Investing Acitivies | n/a | -33.54M | -126.00M | 25.39M | -30.70M |
| Investing Cash Flow | 13.81M | -39.57M | -130.86M | 24.00M | -31.50M |
| Debt Repayment | n/a | n/a | 130.60M | 7.50M | 2.46M |
| Common Stock Repurchased | -19.00K | -450.00K | -38.00K | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 715.00K | 1.35M | 4.37M | -30.00K | 44.80M |
| Financial Cash Flow | 696.00K | 901.00K | 372.13M | 7.51M | 47.30M |
| Net Cash Flow | -59.14M | -125.76M | 189.57M | 6.65M | 4.41M |
| Free Cash Flow | -74.62M | -93.12M | -56.56M | -26.25M | -12.20M |